NCT06584266 Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation
| NCT ID | NCT06584266 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University in Zielona Góra |
| Condition | Atrial Fibrillation and Flutter |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2024-01-01 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational registry is to collect a curated dataset of multimodal imaging data that will serve for development of artificial-intelligence based solutions for prediction of risk and outcomes in patients with atrial fribrillation. Type of study: observational study Study Participants: Patients with atrial fibrillation or atrial flutter who undergo clinically indicated transesophageal echocardiography before catheter ablation or cardioversion. We hypothesize, that automatic analysis of video images of transthoracic echocardiography with deep learning combined with clinical data can predict the presence of left atrial appendage thrombus (LAT). Therefore, our main aim is to create and validate an artificial intelligence model to predict the presence of LAT based on automatic analysis of transthoracic echocardiography with artificial intelligence.
Eligibility Criteria
Inclusion Criteria: \- All patients with AF or AFl in whom TEE will be performed (to assess their eligibility for cardioversion or ablation), hospitalized in a participating center during study period (all consecutive patients). Exclusion Criteria: Age\<18, lack of informed, written consent to the TEE
Contact & Investigator
Konrad Pieszko, MD, PhD
PRINCIPAL INVESTIGATOR
University of Zielona Gora
Frequently Asked Questions
Who can join the NCT06584266 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation and Flutter. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06584266 currently recruiting?
Yes, NCT06584266 is actively recruiting participants. Contact the research team at k.pieszko@cm.uz.zgora.pl for enrollment information.
Where is the NCT06584266 trial being conducted?
This trial is being conducted at Brno, Czechia, Nowa Sól, Poland, Katowice, Poland, Krakow, Poland and 3 additional locations.
Who is sponsoring the NCT06584266 clinical trial?
NCT06584266 is sponsored by University in Zielona Góra. The principal investigator is Konrad Pieszko, MD, PhD at University of Zielona Gora. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.